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INTRODUCTION:  We  present  a  very  rare case  of  gastric  metastasis  mimicking  primary  gastric  cancer  in a
patient  who  had  undergone  surgery  for salivary  duct  carcinoma.
PRESENTATION  OF  CASE:  A 67-year-old  man  had  been  diagnosed  as  having  right  parotid  cancer  and  had
undergone  a right  parotidectomy  and  lymph  node  dissection.  The  histological  diagnosis  was salivary
duct  carcinoma.  One  year  after  the  surgery,  a  positron  emission  tomography–computed  tomography
scan  using  ﬂuorodeoxyglucose  (FDG)  revealed  an  abnormal  uptake  of  FDG in  the  left cervical,  mediasti-
nal,  paraaortic,  and  cardiac  lymph  nodes;  stomach;  and  pancreas.  On  gastroduodenoscopy,  there  was  a
huge,  easily  bleeding  ulcer mimicking  primary  gastric  cancer  at the upper  body  of the  stomach.  Biopsy
revealed  poorly  differentiated  adenocarcinoma.  Therefore,  we  were  unable  to differentiate  between  the
primary  gastric  cancer  and  the  metastatic  tumor  using  gastroduodenoscopy  and  biopsy.  Because  of the
uncontrollable  bleeding  from  the  gastric  cancer,  we performed  an  emergency  palliative  total  gastrec-
tomy.  On histological  examination,  the  gastric  lesion  was found  to  be metastatic  carcinoma  originating
from  the  salivary  duct  carcinoma.
DISCUSSION:  In the  presented  case,  we  could  not  diagnose  the  gastric  metastasis  originating  from  the
salivary  duct carcinoma  even  by endoscopic  biopsy.  This is  because  the  histological  appearance  of  salivary
duct carcinoma  is similar  to  that  of high-grade  adenocarcinoma,  thus, resembling  primary  gastric  cancer.
CONCLUSION:  When  we  perform  endoscopic  examination  of patients  with  malignant  neoplasias,  a  pos-
sibility  of  metastatic  gastric  cancer  should  be taken  into  consideration.
© 2016  The  Authors.  Published  by Elsevier  Ltd  on  behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
There are many histological types of salivary gland neoplasms.
hey include benign and malignant tumors of epithelial, mesenchy-
al, and lymphoid origin. The 2005 World Health Organization
lassiﬁcation of salivary gland tumors is complex and includes
0 benign and 23 malignant entities of epithelial origin [1]. Sali-
ary gland malignancies have an estimated incidence of 0.5–2.5
er 100,000 individuals [2]. Among the malignancies, salivary
uct carcinoma is characterized by an aggressive behavior, early
etastases, local recurrence, and a high mortality rate [3] and con-
Abbreviations: FDG, ﬂuorodeoxyglucose; CT, computed tomography.
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stitutes <1.8% of all major salivary gland tumors [4]. This cancer
predominantly arises in the parotid gland (72%), followed by the
submandibular gland (15%) [4]. However, gastric metastases from
head and neck carcinomas are rare, and their incidence among all
gastric metastases has been reported to range from 1% to 6.2% [5–7].
We report a very rare case of a 67-year-old man  with salivary duct
carcinoma metastasized to the stomach.
2. Presentation of the case
A 67-year-old man  underwent a right parotidectomy for parotid
cancer at our hospital. The histological report showed salivary duct
carcinoma with capsular invasion. The patient received adjuvant
chemoradiotherapy after the surgery. A neck ultrasonography at
1 year after the surgery showed that the left supraclavicular lymph
node was swollen. Histological examination by biopsy revealed
metastatic carcinoma. A computed tomography scan showed gas-
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Computed tomography (CT) scan and positron emission tomography–computed tomography (PET–CT) scan using ﬂuorodeoxyglucose (FDG). (a), An abdominal CT
scan  demonstrated gastric wall thickening with an enlarged perigastric lymph node; (b), An abdominal CT scan demonstrated pancreatic enlargement; (c), A PET–CT scan
using  FDG demonstrated FDG-avid spots in the stomach and cardiac lymph nodes; (d), PET–CT demonstrated FDG-avid spots in the pancreas.
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tig. 2. (a) Gastroduodenoscopy examination. The endoscopic ﬁndings demonstra
evealed poorly differentiated adenocarcinoma [hematoxylin and eosin (HE), ×400
ric wall thickening with an enlarged perigastric lymph node
nd pancreatic enlargement (Fig. 1a and b). A positron emission
omography–computed tomography scan using ﬂuorodeoxyglu-
ose (FDG) showed that there were intensive FDG-avid spots in
he left cervical, mediastinal, paraaortic, and cardiac lymph nodes;
tomach; and pancreas (Fig. 1c and d). A complete blood cell count
evealed a hemoglobin level of 10.5 g/dL, hematocrit of 32.4%,
nd platelets of 206,000/L. A tumor marker study revealed that
he alpha-fetoprotein level was 2.5 ng/mL, carcinoembryonic anti-
en level was 11.1 ng/dL, and the carbohydrate antigen 19-9 level
as 11.0 U/mL. On gastroduodenoscopy, there was a huge, easily
leeding ulcer at the upper body of the stomach (Fig. 2a). Biopsy
evealed poorly differentiated adenocarcinoma (Fig. 2b). Therefore,
e could not differentiate between primary gastric cancer and
 metastatic tumor by gastroduodenoscopy and biopsy. Bleeding
rom the gastric cancer, which was difﬁcult to control by pro-
on pump inhibitor therapy and endoscopic hemostasis, continued
ntil the hemoglobin level decreased to 5.0 g/dL, and the patient
eeded blood transfusion. Therefore, we performed an emergency
alliative total gastrectomy to control the bleeding. Macroscopi-
ally, a clearly demarcated large ulcer (70 mm in size) was seen on
he posterior wall of the subcardia (Fig. 3a and b). Histologically,large ulcerative lesion at the upper body of the stomach; (b) A biopsy specimen
mixed large and small solid nests were observed, which invaded
the serosa layer with lymphatic permeation (Fig. 3c). The cancer
cells were diffusely positive for the HER2 oncogene (Fig. 3d). These
ﬁndings were similar to those obtained for the previous surgi-
cally resected specimen of salivary duct carcinoma. Consequently,
the cancer was consistent with a metastatic carcinoma originating
from the salivary duct carcinoma. The patient made an uneventful
postoperative recovery and received postoperative chemotherapy.
However, he died from tumor regrowth 8 months after the gastrec-
tomy.
3. Discussion
Salivary gland neoplasms are very rare and appear with an
incidence of 0.5–2.5 per 100,000 individuals [2]. Salivary duct
carcinoma is a particularly uncommon adenocarcinoma arising
from the ductal epithelium of major salivary glands. These cancers
predominantly arise in the parotid gland (72%), followed by the
submandibular gland (15%) [4]. In salivary duct carcinoma, distant
metastases are frequent. The most frequent sites involved (in the
order of occurrence) are the lung, bone, and brain [8], whereas the
stomach is an unusual site for metastases. It has been reported that
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rig. 3. Macroscopic and histological features of the resected specimen. a, b, Macros
ests  composed of cancer cells invading the muscularis propria, with marked lym
ositive for an anti-HER2 antibody (×200).
he incidence of metastases to the stomach is 0.8%–5.4% [5,6,9].
oreover, the lung, breast, and esophagus are the common pri-
ary metastatic sites, and metastatic melanoma is also a common
alignancy [6,7]. Among metastases to the stomach, gastric metas-
ases from head and neck carcinomas are rare, and their incidence
mong all gastric metastases has been reported to range from 1%
o 6.2% [5–7]. In general, gastric metastases are associated with an
dvanced stage of disease, and the prognosis is poor. Thus, systemic
hemotherapy suitable for the primary cancer is usually chosen as
 therapy for gastric metastasis. However, it seems that aggressive
urgical treatment is justiﬁed in the cases with severe bleeding,
bstruction, or perforation because it provides effective palliation
10]. We  performed surgical treatment for the gastric metastasis
ith severe bleeding, which could not be controlled by endoscopic
nterventions, and succeeded in controlling the bleeding. Gastro-
uodenoscopy is useful for the identiﬁcation of gastric metastases.
ith regard to the endoscopic appearance of gastric metastases, a
ubmucosal tumor with a central depression, which is called the
bull’s-eye sign,” is well known. However, this typical conﬁgura-
ion was found in only 44% of the cases of gastric metastases. The
emaining lesions were diagnosed as primary gastric cancers [6]. It
as been reported that solitary metastases (similar to primary gas-
ric cancer) were more common than multiple metastases, with
he rate of solitary metastases being 62.5%–66.0% [6,7]. For these
easons, endoscopic differential diagnosis of gastric metastases is
ifﬁcult, such as in our case. It has been reported that endoscopic
iopsy is helpful in reaching the ﬁnal diagnosis because over 90%
f metastatic lesions are conﬁrmed histologically [6,7]. However, in
ur case, we could not diagnose the gastric metastasis originating
rom the salivary duct carcinoma even by endoscopic biopsy. It is
hought that one of the reasons was that the histological appear-
nce of salivary duct carcinoma is similar to that of high-grade
denocarcinoma, thus resembling primary gastric cancer. In con-
lusion, when we perform endoscopic examination of patients with
alignant neoplasias, a close study is required, considering a great
isk of metastatic lesions. Furthermore, if endoscopic biopsy is per-lly, there was  a large ulcerative lesion on the upper body (arrow); c, Note the solid
c permeation (HE, ×100); d, Immunohistochemically, the specimen was diffusely
formed, we should provide pathologists with accurate information
about the clinical history of the patient.
The histopathological ﬁndings on the primary lesion in this case
have been reported in a Japanese article [11]. However, this is the
ﬁrst report on surgically resected gastric metastatic cancer origi-
nating from salivary duct carcinoma.
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